LuminUltra has filed a patent for the first complete, rapid, and on-site COVID-19 wastewater testing solution that will make non-invasive community health assessment far more accessible to both the... Read More
The GeneCount® COVID-19 RT-qPCR Assay Kit has been submitted to the U.S. FDA for Emergency Use Authorization and to Health Canada for an Interim Order.... Read More
Atlantic Business Magazine has named LuminUltra Technologies Ltd.'s Chairman & CEO, Pat Whalen, to their 2020 Top 50 CEO list. Read the full story here.... Read More
NGen has announced $3.5 million in project funding in support of Canada’s COVID-19 response, which includes support for LuminUltra's scale-up.... Read More
BugCount® Online Trial Comparison Report Extensive automated ATP testing trials were performed in two different cooling tower systems. The first two sites were a pilot-scale cooling tower system and... Read More
Until a COVID-19 Vaccine is Available, Widespread Environmental Testing for SARS-CoV-2, Coupled with Effective Disinfection Regimen, Shortens Path to Preserving Public Confidence and Enabling Facilities to Remain Open Amidst... Read More
April 15th, 2020 Fredericton, New Brunswick – Canadian biotechnology leader LuminUltra today announced that it will provide 500,000 urgently needed COVID-19 tests per week to the Canadian federal government... Read More
LuminUltra is committed to keeping you up-to-date on our response during this ever-changing time. Latest updates here.... Read More
Veteran water treatment and waste management industry CEO Heiner Markhoff is now contributing his vast knowledge to LuminUltra Technologies.... Read More
June 20, 2019 – Microbiology control specialist LuminUltra today launched its revolutionary new GeneCount® portfolio of DNA products and services, making it far easier and faster to quantify, specify... Read More
Update your browser to view this website correctly. Update my browser now
